Shandong Xinhua Pharmaceutical Co Ltd

Overview

Shandong Xinhua Pharmaceutical Co Ltd (Shandong Xinhua) is a manufacturer and exporter of chemical synthetics. It produces drugs for central nervous system, cardio-cerebrovascular system, steroids, antipyretics and analgesics, finished dosage forms and pharmaceutical intermediates. Shandong Xinhua’s product portfolio comprises gentamycin sulfate, amikacin sulfate, tobramycin sulfate, chloramphenicol, kanamycin sulfate, clindamycin phosphate, sodium stibogluconate, fructose sodium, diphosphate, ergometrine maleate, etamsylate, rifampin, enoxacina and irisquinone among others. It also offers contract manufacturing services and provides API and pharmaceutical intermediates. The company has its operations in China, the US; and also in Europe and. Shandong Xinhua is headquartered in Zibo, Shandong, China.
Key Stats
Address
No.1 Lutai Avenue, High-tech Zone, ZIBO, Shandong
Headquarters

China

Contact

86 533 2166666

Website
www.xhzy.com
No of Employees

6,497

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

719 [HKG]

Revenue (2020)

$870 m

7.2% (2020 vs 2019)
Net Income (2020)

$47 m

8.2% (2020 vs 2019)
Net Profit Margin

5 %

1.1% (2020 vs 2019)
Market Cap *

$646 m

EPS *

$0.1

  *Note: Ratios based on the share price as of 21-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Shandong Xinhua Pharmaceutical Co LtdSino Biopharmaceutical LtdTianjin Zhongxin Pharmaceutical Group Corp Ltd
Key Information
Headquarters China Hong Kong China
Headquarter City ZIBO - TIANJIN
Headquarter State/Province Shandong - Tianjin
No. of Employees 6,497 24,262 4,840
Entity Type Public Public Public

Products & Services

Shandong Xinhua is a pharmaceutical company. The key products and services offered by the company includes the following:

Products
  • Ibuprofen
  • Analgin
  • Caffeine
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • API Chemical
  • Commercial Dose- Injectables
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Brands
  • Xinhua
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Zhang Daiming Chairman Executive Board - 57 Mr. Zhang Daiming serves as the Chairman and Executive Director at Shandong Xinhua Pharmaceutical Company (Shandong Xinhua). He is a...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2020 Plans/Strategy In April, the company announced its plans to acquire 27% stake in Shandong Xinhua Wanbo…
2019 Contracts/Agreements In September, the company signed an agreement to acquire an additional 33% stake in Shandong…
2018 Acquisitions/Mergers/Takeovers In November, the company acquired the three ibuprofen Abbreviated New Drug Applications in the US…
2014 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2014 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2013 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Shandong Xinhua Medical Trading Company Limited
Shandong Xinhua Pharmaceutical (Europe) Co., Ltd
Shandong Xinhua Pharmaceutical Chemical Design Company Limited
Shandong Xinhua Pharmaceutical Trade Company Limited
Xinhua Pharmaceutical (Gaomi) Company Limited
Xinhua Pharmaceutical (Shouguang) Company Limited
Zibo Xinhua Drug Store Chain Company Limited
Zibo Xinhua-Eastwest Pharmaceutical Company Limited

Deals

Number of Deals
Deal Value (US$ m)